AccuCinch 5018 PMVI
This is a non-randomized, prospective, multi-center Early Feasibility Study of the AccuCinch® Ventricular Repair System in Patients with Prior Mitral Valve Intervention (PMVI) and Recurrent Mitral Regurgitation.

Study Sponsor

Ancora Heart

Study Investigator

Paul Sorajja, MD

Interested in participating in this study?

This is a non-randomized, prospective, multi-center Early Feasibility Study of the AccuCinch® Ventricular Repair System in Patients with Prior Mitral Valve Intervention (PMVI) and Recurrent Mitral Regurgitation.

Eligibility Criteria:

 
  1. Severity of FMR: ≥Moderate  (i.e. 2+)
  2. Patient has had a prior surgical or percutaneous mitral repair procedure >3 months prior to enrollment
  3. LV ejection fraction: ≥20 to ≤40%
  4. Symptom status: NYHA II-IVa

Study Contacts:

Sara Olson, RN
sara.olson@allina.com
612-863-7601